The Microbial Mechanisms of Cardiovascular Disease: Oral Dysbiosis as a Systemic Instigator.
This clinical review examines how oral dysbiosis cardiovascular disease mechanisms create systemic inflammation and vascular damage. Evidence shows periodontal therapy can reduce cardiovascular risk markers, establishing oral health as a modifiable risk…
GLP-1 Cardiovascular Outcomes: Clinical Evidence Review
GLP-1 receptor agonist cardiovascular outcomes evidence highlights meaningful benefits in older women and patients with established cardiovascular disease. This clinical evidence supports expanded use beyond glucose control. Understanding these outcomes…
Young Man’s Heart Attack Linked to Cannabis Use — But One Case Can’t Prove Causation
This cannabis-induced Wellens syndrome case report details a young man's heart attack linked to cannabis use. The report highlights the complexity of attributing causation due to tobacco co-use and other risk factors. It underscores the need for further…
GLP-1 Receptor Agonist Evidence: 20% Heart Attack Risk Drop
GLP-1 receptor agonist cardiovascular outcomes safety data reveal a 20% reduction in heart attack risk. Semaglutide's cardioprotective effects extend beyond glucose control. Medicare Part D coverage expansion in 2026 improves access for high-risk…
Letter by Wu et al Regarding Article, “G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice”.
This letter discusses cannabinoid receptor 2 phosphorylation and its role in diabetic heart injury. The phosphorylation by GRK3 may impair CB2 receptor function in diabetes. Understanding cannabinoid receptor 2 phosphorylation is key to future diabetic…
Cannabis and the Heart and Vessels: What the Science Actually Says
This 2024 narrative review explores cannabinoid involvement in atherosclerosis and other vascular diseases, highlighting both therapeutic promise and evidentiary gaps. The endocannabinoid system plays a complex role in vascular biology through multiple…
The effect of hemp product consumption on blood fatty acid profiles and cardiovascular disease risk factors: results of a randomized, double-blind, crossover clinical trial.
Hemp seeds cardiovascular benefits clinical trial results reveal significant effects on blood fatty acid profiles. This randomized, double-blind, crossover study highlights hemp's impact on cardiovascular disease risk factors. Hemp seeds are rich in…